Patent intelligence · CA
CA 2470342
GRANULAT DE RIBAVIRINE POUR LA PRODUCTION DE COMPRIMES PELLICULES
GRANULAT DE RIBAVIRINE POUR LA PRODUCTION DE COMPRIMES PELLICULES
Patent details — CA 2470342
- Jurisdiction
- CA
- Status
- expired
- Grant date
- Jul 3, 2003
- Expiration
- Jun 28, 2023
- Applicant
- BIOPARTNERS GMBH [CH]
- CPC classes
- A61K 9/ 16 A I, A61K 31/ 7056 A I, A61K/91635, A61K/91652
Quick answer
CA 2470342 (GRANULAT DE RIBAVIRINE POUR LA PRODUCTION DE COMPRIMES PELLICULES) is held by BIOPARTNERS GMBH [CH]. Status: expired. Granted Jul 3, 2003. Expires Jun 28, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BIOPARTNERS GMBH [CH]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 16 A I, A61K 31/ 7056 A I, A61K/91635, A61K/91652, A61K31/7056, A61K9/16
More from BIOPARTNERS GMBH [CH]
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 2470342?
CA 2470342 (GRANULAT DE RIBAVIRINE POUR LA PRODUCTION DE COMPRIMES PELLICULES) is held by BIOPARTNERS GMBH [CH]. Status: expired. Granted Jul 3, 2003. Expires Jun 28, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns CA 2470342?
BIOPARTNERS GMBH [CH] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 2 pharmaceutical patents for this assignee.
When does CA 2470342 expire?
Our index shows an expiration date of Jun 28, 2023 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.